Veru to Report Fiscal 2023 Second Quarter Financial Results on May 11, 2023
April 27, 2023 06:45 ET
|
Veru Inc.
MIAMI, FL, April 27, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related...
Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023
January 26, 2023 08:30 ET
|
Veru Inc.
MIAMI, FL, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...